gip and glp-1 weight loss Indications for GLP-1/GIP RA Summary Sheet Beyond! GLP-1, GLP1/GIP, and Triple G:
Description
Recent data suggests that use of GLP-1s is highest for perimenopausal women in the United States
We walk through what the data actually showed, why the comparison was misleading, how trial design and dosing matter, and why Phase 1 results should never be treated as superiority claims
Dry mouth, fatigue, nausea
Treasure Island, FL, USA: 2024
Short acting agents may be best suited for patients with type 2 diabetes that includes exaggerated postprandial glucose excursions , and for co-administration with basal insulin therapy (Guo, 2016
